Skip to main content
. Author manuscript; available in PMC: 2013 Sep 30.
Published in final edited form as: Eur J Pain. 2011 Dec 19;16(3):370–380. doi: 10.1002/j.1532-2149.2011.00021.x

Table 1.

Participant characteristics.

Variable Participant type
Healthy control (n = 39) LBP (n = 37)
Age (years)* 30.9 ± 8.26 35.2 ± 9.86
Gender (% female)* 71.8 48.6
Race (%)
 White 87.2 78.4
 African-American 10.3 8.1
Ethnicity (% non-Hispanic) 94.9 89.2
Chronic pain duration (median, in months) 70.2
Past month chronic pain intensity (0–100) 44.1 ± 16.91
Resting plasma BE (ng/mL) 1.5 ± 2.41 1.8 ± 2.57
BDI** 2.8 ± 3.04 7.5 ± 5.88
STAI** 32.1 ± 6.97 38.1 ± 8.38
PANAS–Negative Affect 15.4 ± 3.99 16.8 ± 4.20

Values are presented as percentages or means ± SD. BDI, Beck Depression Inventory; BE, beta-endorphin; LBP, chronic low back pain; PANAS, Positive and Negative Affect Scales; SD, standard deviation; STAI, State Trait Anxiety Inventory.

*

p < 0.05.

**

p < 0.01.

HHS Vulnerability Disclosure